Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most artificial intelligence (AI) tools rely on dermoscopic images alone, they ...
Gastric cancer remains one of the leading causes of cancer-related mortality worldwide, primarily due to late-stage diagnosis ...
The integration of AI into digital pathology has the potential to transform cancer diagnostics by enabling scalable, ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results. Results ...
BXQ-350 efficacy and safety evaluation in first line mCRC patients: A phase 1b/2 study of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 plus bevacizumab in ...
Man’s best friend may become cancer’s worst enemy.
At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to ...
The AI in cancer diagnostics market presents significant opportunities driven by advancements in AI and machine learning ...
AI medical imaging market is projected to exceed $20B by 2035. Generative models address class imbalances in medical imaging ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results